Measures lung function and inflammation in women in The Gambia
Checks how well women's lungs work by breathing tests and exhaled-air testing.
Key facts
- Who runs it
- Permian Health Lung Institute
- Where
- Kanifing, GambiaSee the site
- Trial code
- Registry title
- Permian Health Women's Lung Health Study
- Status
- Not yet recruiting
- People taking part
- 350 people, planned
- Started
- Dec 2023
- Expected to end
- Dec 2026
- Type of study
- Observational
- Record updated
- 8 September 2023
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The study is looking for women aged over 15 who live in households in The Gambia. It will measure lung function with a breathing test.
- Age
- Older than 15 years
- Sex
- Women only (self-identified female)
- Earlier treatment
- People with known active lung disease (including TB) who are on treatment cannot join.
Main reasons for not taking part
- Under 15 years old
- Not a resident household member
- Acutely unwell
- Pregnant
- Known active lung disease (including TB) on treatment
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Self-identified female sex
- Age > 15 years: This age cutoff was chosen (as opposed to 18) because of the unique cultural norms and practices in the country where experiences and exposures occur at an earlier age than women in Western countries
Who cannot take part
- Any known history of active pulmonary disease (including TB) on treatment
- Age < 15 years
- Non-resident household member
- Any acutely unwell individual
- Pregnancy
- Individuals unable or unwilling to give consent
Where in Gambia
- GamcotrapKanifing, GambiaContact: Musa D JallowNo longer taking part
About the trial
What the trial wants to find out
The goal of this cross-sectional observational study is to estimate the prevalence of lung function impairment as measured by spirometry in a population of Gambian women aged 15 and older. The main question[s] it aims to answer are:
Read full original descriptionShow less
* What is the prevalence of lung function impairment in Gambian women * What is the prevalence of eosinophilic inflammation in Gambian women
Consenting participants will undergo
* Spirometry * Fractional exhaled nitric oxide (FENO) testing * α1-antitrypsin testing in patients with lung function impairment as assessed by spirometry
The group in the trial
- Gambian Women
Gambian women aged 15 and older with lung function impairment as measured by spirometry
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Permian Health Women's Lung Health Study
- Plain-language title
- Measures lung function and inflammation in women in The GambiaGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 8 September 2023